Elin Baddeley

BSc (Hons)

2026

• Sivell, S. et al. 2026. A systematic review of the implementation of cancer-specific holistic needs assessment (HNA) in adult clinical practice, and applicability to the brain tumour population. Supportive Care in Cancer 34 (4) 399. (10.1007/s00520-026-10609-x)
• Baddeley, E. et al. 2026. Clinician perspectives on antithrombotic therapy management in advanced cancer: a multi-national qualitative study. Research and Practice in Thrombosis and Haemostasis 10 (3) 103427. (10.1016/j.rpth.2026.103427)
• Højen, A. A. et al., 2026. Capturing the late complications of venous thromboembolism. Research and Practice in Thrombosis and Haemostasis 10 (3) 103420. (10.1016/j.rpth.2026.103420)

2025

• Baddeley, E. et al. 2025. "Who am I to say that I'm not going to take it": patient perspectives on decisions about antithrombotic therapy in the context of advanced cancer. Thrombosis Research: Vascular Obstruction, Hemorrhage and Hemostasis 253 109399. (10.1016/j.thromres.2025.109399)
• Baddeley, E. et al. 2025. Wellbeing and coping: Key aspects of unmet need of people living with glioma. Neuro Oncology Practice 12 (3), pp.413-425. npae127. (10.1093/nop/npae127)
• Edwards, M. et al. 2025. Involving patients and the public in cancer associated thrombosis research: a strategy for success.. Thrombosis Update 18 100196. (10.1016/j.tru.2024.100196)
• Staffurth, J. N. et al. 2025. The impact of specialised gastroenterology services for pelvic radiation disease (PRD): Results from the prospective multi-centre EAGLE study. PLoS ONE 20 (1) e0303356. (10.1371/journal.pone.0303356)

2023

• Retzer, A. et al., 2023. Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study. Neuro-Oncology Advances 5 (1) vdad096. (10.1093/noajnl/vdad096)
• Baddeley, E. et al. 2023. Understanding the holistic needs of people living with glioma and their caregivers: A thematic analysis of the semi-structured interviews for the COBRA study. Presented at: European Association of Neuro-Oncology (EANO) Rotterdam 21-24 September 2023. Vol. 25.Vol. S2. (10.1093/neuonc/noad137.194)
• Goedegebuur, J. et al., 2023. Towards optimal use of antithrombotic therapy of people with cancer at the end of life: a research protocol for the development and implementation of the SERENITY shared decision support tool. Thrombosis Research 228 , pp.54-60. (10.1016/j.thromres.2023.05.008)
• Bravington, A. et al., 2023. Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction. PLoS ONE 18 (8) e0289501. (10.1371/journal.pone.0289501)
• Goss, S. et al. 2023. Achieving consistency and consensus in evaluating the impact of palliative care service interventions: development of an effectiveness core outcome set for adult palliative care services in Wales. Presented at: The Marie Curie Research Conference 2023 Virtual 6-10 February 2023. Vol. 13., pp.A6-A7. (10.1136/spcare-2023-MCRC.15)

2022

• Bravington, A. et al., 2022. The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: a systematic review. Palliative Medicine 36 (9), pp.1336-1350. (10.1177/02692163221122352)
• Baddeley, E. et al. 2022. The impact of glioma on quality of life: findings from a mixed methods study to develop a core outcome set for glioma interventional trials (COBra Study). Presented at: International Society for Quality of Life Research (ISOQOL) 29th Annual Conference Prague, Czech Republic 19-22 October 2022.
• Baddeley, E. et al. 2022. The experiences of people with glioma and their caregivers: Living with uncertainty and long-term consequences (COBra Study). Presented at: 17th World Congress of the EAPC 2021 Online 6-8 October 2021. Vol. 24.Vol. Supp.4. Oxford University Press. , pp.iv2. (10.1093/neuonc/noac200.007)
• Retzer, A. et al., 2022. Core outcomes in brain tumour trials – the COBra study review of glioma trial registration data [Abstract]. Neuro-Oncology 24 (10.1093/neuonc/noac200.019)
• Retzer, A. et al., 2022. Development of a core outcome set and identification of patient-reportable outcomes for primary brain tumour trials: protocol for the COBra study. BMJ Open 12 057712. (10.1136/bmjopen-2021-057712)
• Baddeley, E. et al. 2022. The importance of treatment tolerability for people with glioma: registry review and qualitative findings from the COBra Study.. Neuro-Oncology 24 (S2), pp.ii47. (10.1093/neuonc/noac174.162)
• Goss, S. et al. 2022. Development of a core outcome set for evaluating the effectiveness of adult palliative care services in Wales. Project Report.NHS Wales and Marie Curie Palliative Care Research Centre.
• Baddeley, E. et al. 2022. Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: A qualitative systematic review. Palliative Medicine 36 (6), pp.895-911. (10.1177/02692163221081331)
• Baddeley, E. et al. 2022. Evaluation of patient and public involvement in the development of a patient reported outcome set in brain tumour trials (COBra Study). Presented at: National PROMs Annual Research Conference Online 14-15 June 2022.

2021

• Baddeley, E. et al. 2021. A mixed-methods study to evaluate a patient-designed tool to reduce harm from cancer-associated thrombosis: The EMPOWER study. Research and Practice in Thrombosis and Haemostasis 5 (5) e12545. (10.1002/rth2.12545)

2020

• Baddeley, E. et al. 2020. Development of a core outcome set to use in the research and assessment of malignant bowel obstruction: protocol for the RAMBO study. BMJ Open 10 (6) e039154. (10.1136/bmjopen-2020-039154)